http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18064064

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 1147
issn 0006-2952
issueIdentifier 9
pageRange 1139-1147
publicationName Biochemical Pharmacology
startingPage 1139
bibliographicCitation Cassinelli G, Ronchetti D, Laccabue D, Mattioli M, Cuccuru G, Favini E, Nicolini V, Greco A, Neri A, Zunino F, Lanzi C. Concomitant downregulation of proliferation/survival pathways dependent on FGF-R3, JAK2 and BCMA in human multiple myeloma cells by multi-kinase targeting. Biochem Pharmacol. 2009 Nov 01;78(9):1139–47. doi: 10.1016/j.bcp.2009.06.023. PMID: 19555670.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_762a0ccf0d1731bc65fe3bd50a11a204
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9398388ee562da0e3392c0e3e7560ef0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e28860bd4eacf607ba2bb8f9b3ad4e13
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_781c494062fdb43fa9d40c0f7fd3e935
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b915eed44e35c93cc2fb160db266bec9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_29a61d991ee46d47caa702a75e27241e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_49bd8fb69b2bc2464be73b54409b60b4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_04695579795983d84f960a4fe6334ab4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1f33f8795f7d6d21bc80f66857b319d1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3b2b397f8190004adc52856f3dd5e09e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d7b5e53906dc8dfd7ca0717c9eb5a8c8
date 2009-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/19555670
https://doi.org/10.1016/j.bcp.2009.06.023
isPartOf https://portal.issn.org/resource/ISSN/0006-2952
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1015
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Concomitant downregulation of proliferation/survival pathways dependent on FGF-R3, JAK2 and BCMA in human multiple myeloma cells by multi-kinase targeting
discusses http://id.nlm.nih.gov/mesh/M0230427
http://id.nlm.nih.gov/mesh/M0203030
http://id.nlm.nih.gov/mesh/M0492351
http://id.nlm.nih.gov/mesh/M0026502
http://id.nlm.nih.gov/mesh/M0457532
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D053301Q000378
http://id.nlm.nih.gov/mesh/D015536
http://id.nlm.nih.gov/mesh/D002470Q000187
http://id.nlm.nih.gov/mesh/D009101Q000473
http://id.nlm.nih.gov/mesh/D017468Q000378
http://id.nlm.nih.gov/mesh/D047428Q000494
http://id.nlm.nih.gov/mesh/D049109Q000187
http://id.nlm.nih.gov/mesh/D053614Q000378
hasSubjectTerm http://id.nlm.nih.gov/mesh/D015153
http://id.nlm.nih.gov/mesh/D045744
http://id.nlm.nih.gov/mesh/D009101Q000201
http://id.nlm.nih.gov/mesh/D047468
http://id.nlm.nih.gov/mesh/D020869
http://id.nlm.nih.gov/mesh/D009101Q000235
http://id.nlm.nih.gov/mesh/D009101Q000378
http://id.nlm.nih.gov/mesh/D017209
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D002470Q000502
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_472b28cee6c37ce9d58de4aa1dc6d7ef
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c1abd97d40c50d5f1bbce15f3f202e19
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_132a8504e7423e57e5565c4615cd0cd2
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID101929972
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fe0d872c4ea3e7d9f07488fc82841cc8
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_54e32599939667ce8030f6c1725ceac0
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8530
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1f86fa8cd4f6beedf83ce7a5e3dfc9ca
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1749978
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_01cd44f087e71c1fa8b1d509b452d932
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_12addc602e83ea6fbdd28c23a70841e0

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/conserveddomain/PSSMID276919
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459

Total number of triples: 65.